DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $269,000 | -88.8% | 1,523 | -90.8% | 0.40% | +235.8% |
Q3 2019 | $2,401,000 | -52.5% | 16,621 | -64.3% | 0.12% | -47.8% |
Q3 2018 | $5,052,000 | -10.6% | 46,500 | -18.8% | 0.23% | 0.0% |
Q2 2018 | $5,654,000 | +48.5% | 57,300 | +47.3% | 0.23% | +50.3% |
Q1 2018 | $3,808,000 | +16.9% | 38,900 | +10.8% | 0.15% | +6.2% |
Q4 2017 | $3,257,000 | -57.1% | 35,100 | -61.0% | 0.14% | -64.3% |
Q2 2017 | $7,595,000 | +31.8% | 90,000 | +33.5% | 0.40% | +51.5% |
Q1 2017 | $5,764,000 | -24.2% | 67,400 | -31.0% | 0.27% | -41.4% |
Q4 2016 | $7,604,000 | +922.0% | 97,700 | +928.4% | 0.45% | +88.4% |
Q3 2016 | $744,000 | -76.1% | 9,500 | -69.2% | 0.24% | +55.5% |
Q2 2016 | $3,112,000 | +129.3% | 30,819 | +110.9% | 0.16% | +142.2% |
Q4 2015 | $1,357,000 | +72.2% | 14,614 | +57.4% | 0.06% | +137.0% |
Q1 2015 | $788,000 | -86.7% | 9,284 | -86.6% | 0.03% | -87.8% |
Q4 2014 | $5,922,000 | +472.7% | 69,098 | +425.7% | 0.22% | +309.3% |
Q2 2014 | $1,034,000 | -81.6% | 13,145 | -82.4% | 0.05% | -81.8% |
Q1 2014 | $5,611,000 | +793.5% | 74,814 | +819.7% | 0.30% | +800.0% |
Q4 2013 | $628,000 | – | 8,135 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |